Web Results

www.state.nj.us/treasury/purchase/pdf/decisions/2016/IMO%20RFP%2016-X-24217%20GlaxoSmithKline%20LLC.pdf

Apr 8, 2016 ... Dear Mr. Adedeji: This correspondence is in response to your letter of protest dated and received March 22, 2016, referencing the subject Request for Proposal (RFP) and regarding the proposal submitted by. GlaxoSmithKline LLC ( GSK) to the Procurement Bureau (Bureau) of the Division of Purchase and.

finance.yahoo.com/news/gsk-wins-235-million-teva-224152421.html

Jun 21, 2017 ... GSK said that as a result, Teva induced healthcare providers to infringe its patent by selling a generic version of the drug and marketing it as a substitute for Coreg. The case is GlaxoSmithKline LLC et al v. Teva Pharmaceuticals USA Inc, U.S. District Court, District of Delaware, No. 14-cv-00878. (Reporting ...

www.fiercebiotech.com/biotech/updated-glaxosmithkline-rips-into-rtp-r-d-group-chopping-900-plus-jobs-global

Dec 3, 2014 ... Hobbled by sliding sales of Advair, GlaxoSmithKline's U.S. group started to chop away at its large organization in North Carolina and Philadelphia on Wednesday as Glaxo's North American chief Deirdre Connelly began to outline exactly where the ax will fall. The company ($GSK) says that the bulk of the ...

www.cnbc.com/2017/04/05/drugmaker-gsk-recalling-nearly-600000-asthma-inhalers-in-us.html

Apr 5, 2017 ... GSK is voluntarily recalling over 593000 Ventolin asthma inhalers from the US due to a defect that may cause them to deliver fewer doses of the medicine than indicated.

oag.ca.gov/system/files/attachments/press_releases/n2523_conformed_copy_complaint.pdf

Jun 22, 2011 ... In or around January 2001, Defendants' Cidra manufacturing facility became one of their largest manufacturing facilities worldwide and a major supplier of prescription drugs to the. United States. Defendants were responsible for making a complex portfolio of drugs, including pills, creams, ointments, and ...

medlibrary.org/lib/rx/meds/coreg-4

Sep 15, 2017 ... GlaxoSmithKline LLC: COREG is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure (1.1) left...

www.oyez.org/cases/2011/11-204

Apr 16, 2012 ... Michael Christopher and Frank Buchanan began working for GlaxoSmithKline LLC ("Glaxo") as pharmaceutical sales representatives ("PSRs") in 2003. Glaxo developed, produced, marketed and sold pharmaceutical products to distributors or retail pharmacies, which subsequently sell those products to ...

www.pharmaceutical-technology.com/projects/zebulon

Glaxo Wellcome, (now known as GlaxoSmithKline), a UK-based pharmaceuticals company, instigated a project in 1999 to expand the 652,000ft² manufacturing and packaging plant in Zebulon, NC. The new 220,000ft² stand-alone facility was purpose built for light manufacturing of dry powder inhalers containing medicines  ...

oig.hhs.gov/fraud/cia/agreements/GlaxoSmithKline_LLC_06282012.pdf

Jun 28, 2012 ... GlaxoSmithKline LLC (GSK) hereby enters into this Corporate Integrity. Agreement (CIA) with the Office of Inspector General (OIG) of the United States. Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and ...